Managing Glucocorticoid Induced Osteoporosis in Rheumatology

Description

Rheumatology Cases on the Web (COWs) is an online case-based series that provides an in-depth review of basic and clinical aspects and the effect of recent advances in rheumatic diseases. Expert faculty offer succinct cases on biologic safety, tuberculosis, cardiovascular disease and rheumatoid arthritis, spondyloarthropathies, and lupus, as well as the rationale for both right and wrong answers within each case.

The Managing Glucocorticoid Induced Osteoporosis in Rheumatology case reviews osteoporosis in inflammatory rheumatic disease settings, including current guidelines in clinical practice for steroid-induced osteoporosis.
Learning Objectives

Determine which patients on glucocorticoid therapy need treatment with an osteoporosis medication.
Summarize current American College of Rheumatology (ACR) recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
Review the use of the absolute fracture risk assessment model within the ACR recommendations.
Decide on treatment options to prevent bone loss and fractures in patients on glucocorticoid therapy.

Target Audience

This educational series is designed for rheumatologists, internal medicine physicians and other health care professionals interested in rheumatic diseases.
Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Activity Director and Faculty
Activity Director and Faculty

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic
Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Faculty

Chad Deal, MD
Head, Center for Osteoporosis and Metabolic Bone Disease
Department of Rheumatologic and Immunologic Diseases
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Leonard H. Calabrese, DO

Abbvie 	Consulting

	

BMS 	Consulting; Teaching and Speaking

	

Centocor 	Consulting

	

Crescendo 	Teaching and Speaking

	

Genentech/Roche 	Consulting; Teaching and Speaking

	

GSK 	Consulting

	

Pfizer 	Consulting

	

Sanofi Aventis 	Consulting

	

UCB 	Consulting

Chad Deal, MD

Amgen 	Consulting; Teaching and Speaking;

Membership on advisory committee or review panels

Lilly 	Consulting; Teaching and Speaking;

Membership on advisory committee or review panels